# Nuclide record nct06122584 (trial). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/trials/nct06122584/>
  a schema:MedicalTrial ;
  nuclide:kind "trial" ;
  schema:identifier "nct06122584", "NCT06122584" ;
  schema:name "Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer"@en ;
  schema:description "A phase 3 trial of PSMA-1007 F-18 run by ABX advanced biochemical compounds GmbH in prostate cancer, now recruiting."@en ;
  schema:url <https://nuclide.cc/trials/nct06122584/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06122584> ;
  nuclide:status "recruiting" ;
  nuclide:tag "ctgov-ingest" ;
  nuclide:phase "3" ;
  nuclide:related <https://nuclide.cc/isotopes/f-18/> ;
  nuclide:indications <https://nuclide.cc/indications/prostate/>, <https://nuclide.cc/indications/prostate-high-risk/> ;
  nuclide:drugs <https://nuclide.cc/drugs/psma-1007-f18/> ;
  nuclide:companies <https://nuclide.cc/companies/abx-advanced-biochemical-compounds/> .